Why are the prescription medications you take so expensive?

Why are the prescription medications you take so expensive?


Check your health insurance plan’s preferred drug list or formulary, as they generally have lower costs than other comparable medications.

Split pills: If each pill contains more than the recommended dose and can be split, under certain circumstances, the cost of the prescription will be lower. For example, if you normally take a 25 mg pill, splitting a 50 mg pill in half could result in lower copays and drug costs. If your calculations don’t add up, ask your pharmacist.

Evaluate your options with a pharmacist and compare costs at several pharmacies. There are cases where not using your insurance results in a lower cost.

Consider ordering online from a mail-order company (such as Blink Health or Cost Plus Drug Company). However, expenses made through these websites may not be deductible from your insurance deductible. Additionally, online prices are not always cheaper.

These steps can be time-consuming and beneficial for some people more than others. The unfortunate reality is that your wallet may not be significantly affected even if you try your hardest.


These are my top five candidates:

The financial motivation of drug manufacturers. Pharmaceutical companies regularly dismiss this idea. They claim that creating new drugs and conducting the clinical trials necessary to demonstrate their effectiveness and safety is expensive. FDA approval of drugs is a challenging and expensive process, and many promising drugs end up failing.

However, a recent study that was published in JAMA Network Open found no link between the amount of money a pharmaceutical company spends on R&D and the cost of the drug. Most of the top 30 pharmaceutical companies generate billions of dollars in profits, even after deducting R&D expenses. Furthermore, the same drugs produced by the same companies for the same health problems They typically cost much less in Europe than in the US. because drug prices are negotiated there.

PBM or pharmacy benefit managers, manage prescription drug benefits for Medicare, commercial insurance, and large employers. PBMs negotiate with pharmacies and health insurers to reduce costs. They play a role in determining costs for patients and which medications to cover. His fees and incentives, which often represent a portion of the total amount spent on medications and can encourage the approval of more expensive medications, add to the bottom line costs borne by healthcare consumers. A plethora of state and federal laws They aim to restrict the capabilities of PBMs and the degree of transparency in their business practices.

Buy costs. Through increased co-pays, deductibles and premiums, insurers have progressively shifted costs to patients in recent years. This is sometimes justified on the grounds that it encourages patients to seek medical care only when absolutely necessary; Naturally, this could also discourage people from seeking care even when it is appropriate.

Legal maneuvers. To prolong their time with a monopoly on a specific drug, many pharmaceutical companies sue potential competitors and file multiple patents (see example). Alternatively, they modify already approved drugs to produce “me too” drugs that they can patent as novel medicines. Some pharmaceutical companies buy the rights to older drugs and subsequently increase the price. Others have avoided price competition by buy another drug maker or merge with them.

Advertising directed to the consumer.. Pharmaceutical companies invest billions in advertising (almost $8.1 billion in 2022). Drug prices increase due to marketing expenses, which also increase demand for newer, highly marketed drugs. Compared to older drugs, advertised drugs are often much more expensive (and not always better). This may explain why this type of advertising is banned in most other countries.

What could prevent drug prices from increasing?
Prescription drug costs will likely remain high for some time, but three developments may moderate price increases in the coming years:

He US Government Can Now Negotiate Medicare Drug Prices thanks to the Inflation Reduction Act of 2022, which should result in cheaper prescription drug costs. In 2026, the first ten medicines whose price is protected will come into force. These medications include the diabetes drug sitagliptin (Januvia) and the blood thinner apixaban (Eliquis). More medications will be added to this list each year. It could have a significant effect if you take any of these medications. However, it is not a one-size-fits-all solution, as there are currently more than 20,000 approved medications available.

Along with other proposed federal and state laws aimed at protecting people from the exorbitant costs of prescription drugs, the The FDA recently approved the importation of Canadian medications from Florida.

Lawmakers seem more interested than ever in supporting organizations like AARP, Consumer Unionand Patients for affordable medications who work to reduce the cost of prescription drugs.

In short, let’s be honest: the people who create and distribute drugs are encouraged to set their prices well above what many people can afford in our complex and dysfunctional healthcare system. Plus, there’s a limit to what you can accomplish alone. In reality, a review is necessary to eliminate intermediaries, who increase costs without always adding value.

Do what you can, even if it has minimal effect, until we get there. Doing everything you can to maintain your health may be the most important thing you do. Ultimately, the most effective approach to reducing the amount of money you spend on prescription medications is to not need them.



Source link